US20040159821A1 - Magnetizable device - Google Patents
Magnetizable device Download PDFInfo
- Publication number
- US20040159821A1 US20040159821A1 US10/782,356 US78235604A US2004159821A1 US 20040159821 A1 US20040159821 A1 US 20040159821A1 US 78235604 A US78235604 A US 78235604A US 2004159821 A1 US2004159821 A1 US 2004159821A1
- Authority
- US
- United States
- Prior art keywords
- particles
- ferromagnetic
- magnetic
- ferritin
- recording medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B5/00—Recording by magnetisation or demagnetisation of a record carrier; Reproducing by magnetic means; Record carriers therefor
- G11B5/84—Processes or apparatus specially adapted for manufacturing record carriers
- G11B5/855—Coating only part of a support with a magnetic layer
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0063—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use in a non-magnetic matrix, e.g. granular solids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
- Y10T428/256—Heavy metal or aluminum or compound thereof
- Y10T428/257—Iron oxide or aluminum oxide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
Definitions
- This invention relates to a magnetizable device which comprises a magnetic layer composed of domain-separated, nanoscale (e.g. 1-100 nm) ferromagnetic particles.
- the magnetizable device of the invention may be used as a magnetic storage device having improved data storage characteristics.
- the invention relates to magnetic storage media comprising single-domain, domain-separated, uniform, ferromagnetic nanoscale (e.g. 1-100 nm) particles which may be arranged into a regular 2-D packed array useful in the storage of information.
- this invention details the use of an iron storage protein, ferritin, whose internal cavity is used to produce the nanoscale particles.
- Ferritin is utilised in iron metabolism throughout living species and its structure is highly conserved among them. It consists of 24 subunits which are arranged to provide a hollow shell roughly 8 nm in diameter. The cavity normally stores 4500 iron(III) atoms in the form of paramagnetic ferrihydrite. However, this ferrihydrite can be removed (a ferritin devoid of ferrihydrite is termed “apoferritin”) and other materials may be incorporated. Examples include ceramics, superparamagnetic magnetite, acetaminophen, and even the sweetener aspartame. To address magnetic media concerns, the invention incorporates ferromagnetically ordered materials.
- a magnetizable device which comprises a magnetic layer composed of domain-separated, ferromagnetic particles each of which has a largest dimension no greater than 100 nm.
- a magnetic recording medium which includes a magnetizable layer, wherein said magnetizable layer comprises a plurality of ferromagnetic particles each having a largest dimension no greater than 100 nm, and each of which particles represents a separate ferromagnetic domain.
- the magnetizable layer is preferably supported on a non-magnetic substrate.
- a magnetic composition comprising a plurality of ferromagnetic particles each of which is bound to an organic macromolecule, and each of which has a largest dimension no greater than 100 nm.
- said organic macromolecule is ferritin from which the normal core ferrihydrite has been removed and replaced by a ferromagnetic particle.
- ferromagnetic embraces materials which are either “ferromagnetic” and “ferrimagnetic”. Such usage is common in the electrical engineering art.
- the ferromagnetic particles used in the invention should be of a material and size such that they possess ferromagnetic properties at ambient temperatures (e.g. 15° C. to 30° C.),
- the ferromagnetic particles each have a largest dimension no greater than 50 nm, more preferably less than 25 nm and most preferably smaller than 15 nm.
- the largest dimension of the ferromagnetic particles should not be so small that the particle will lose its ferromagnetic property and become superparamagnetic at the desired operating temperature of the recording medium. Typically, for operation at ambient temperature, this means that the magnetic particles will normally be no smaller than about 3 nm in their largest diameter.
- the distance between adjacent ferromagnetic domains is preferably as small as possible to permit the maximum number of discrete domains in a given area, and provide the maximum storage capacity for the recording medium.
- the actual lower limit will vary for different materials and other conditions such as the temperature at which the recording medium is to be used. The key requirement, however, is that neighbouring domains should not be able to interfere magnetically with each other to the extent that the magnetic alignment of any domain can be altered by neighbouring domains.
- the lower limit on the spacing of the domains is about 2 nm.
- the distance between adjacent domains will be determined by the density of discrete domains required. Typically, however, to take advantage of the miniaturization possibilities provided by the invention, the distance between adjacent domains will be no greater than 10 nm.
- the particles will be uniform in size, by which we mean that the particles do not vary in largest diameter by more than about 5%.
- One of the advantages of the use in the invention of an organic macromolecule which binds a magnetic particle by surrounding it is that this can be used to select particles of a uniform size.
- the particles are spheroidal, it will be the diameter of the particles which must be no greater than 100 nm.
- each ferromagnetic particle is encased, or partially encased, within an organic macromolecule.
- macromolecule means a molecule, or assembly of molecules, and may have a molecular weight of up 1500 kD, typically less than 500 kD.
- Ferritin has a molecular weight of 400 kD.
- the macromolecule should be capable of binding by encasing or otherwise organising the magnetic particle, and may therefore comprise a suitable cavity capable of containing the particle; a cavity will normally be fully enclosed within the macromolecule.
- the macromolecule may include a suitable opening which is not fully surrounded, but which nevertheless is capable of receiving and supporting the magnetic particle; for example, the opening may be that defined by an annulus in the macromolecule.
- suitable macromolecules which may be used in the invention are proteins, for example the protein apoferritin (which is ferritin in which the cavity is empty), flagellar L-P rings, cyclodextrins, self-assembled cyclic peptides.
- they may be organised on the macromolecule, such as on a bacterial S-layer.
- ferromagnetic particles are inorganic-silica networks such as MCM type materials, dendrimers and micellar type systems.
- the presently preferred macromolecule for use in the invention is the apoferritin protein which has a cavity of the order of 8 nm in diameter.
- the ferri- or ferromagnetic particles to be accommodated within this protein should have a diameter no greater than 8 nm.
- the particles are preferably arranged in a 2-D ordered array which would yield an ultrahigh-density magnetic media.
- the ferromagnetic material may be a metal, such as cobalt, iron, or nickel; a metal alloy, such as an alloy which contains aluminium, barium, bismuth, cerium, chromium, cobalt, copper, iron, manganese, molybdenum, neodymium, nickel, niobium, platinum, praseodymium, samarium, strontium, titanium, vanadium, ytterbium, yttrium or a mixture thereof; a metal ferrite such as a ferrite containing barium, cobalt, or strontium; or an organic ferromagnetic material.
- a metal such as cobalt, iron, or nickel
- a metal alloy such as an alloy which contains aluminium, barium, bismuth, cerium, chromium, cobalt, copper, iron, manganese, molybdenum, neodymium, nickel, niobium, platinum, praseodymium,
- the blocking temperature the temperature at which a particle becomes superparamagnetic (the “blocking temperature”) for a given material at a fixed volume.
- the fixed volume is 8 nm in ferritin.
- a cobalt metal particle with only crystalline anisotropy that value being 45 ⁇ 10 5
- the blocking temperature is 353° K. This is within the range of temperatures experienced within a hard disk drive, and the cobalt particles may prove to be a useful storage medium.
- there are other considerations such as the materials' coercivity, moment, saturation magnetisation, and relaxation time.
- Ferritin is utilised in iron metabolism throughout living species and its structure is highly conserved among them. It consists of 24 subunits arranged in a 432 symmetry which provide a hollow shell roughly 8 nm in diameter. The cavity normally stores 4500 iron(III) atoms in the form of paramagnetic ferrihydrite.
- this ferrihydrite can be removed (a ferritin devoid of ferrihydrite is termed “apoferritin”) and other materials may be incorporated.
- the subunits in ferritin pack tightly, however there are channels into the cavity at the 3-fold and 4-fold axes. Lining the 3-fold channels are residues which bind metals such as cadmium, zinc, and calcium. By introducing such divalent ions one can potentially bind ferritin molecules together, or at least encourage their proximal arrangement.
- One method of preparing a 2-D packed array of ferromagnetically ordered particles of uniform size up to 8 nm includes the removal of the ferrihydrite core from the native ferritin in aqueous solution, the incorporation of ferromagnetically ordered cobalt metal particles by sodium borohydride reduction of the aqueous Co(II) solution into the ferritin cavities, the generation of a narrow size distribution through ultracentrifugation, the injection of particles into an MES/glucose subphase solution upon which the 2-D array assembles, and the transfer of the 2-D array to a substrate which is then carbon coated.
- the ferritin source may be a vertebrate, invertebrate, plant, fungi, yeast, bacteria, or one produced through recombinant techniques.
- a metal alloy core may be produced by sodium borohydride reduction of a water soluble metal salt.
- Other oxidation methods include carbon, carbon monoxide, hydrogen, or hydrazine hydrate solution.
- a suitable-solution may be oxidised to yield a metal ferrite core. Oxidation may be chemical or electrochemical to yield the metal ferrite.
- divalent metal salts containing cadmium, calcium, or zinc may be added into the subphase solution to aid in particle ordering.
- the 2-D array may be coated with carbon-based films such as hydrogenated or nitrogen doped diamond-like carbon, or with silicon-based films such as silicon dioxide.
- ferritin may be used to enclose a ferromagnetic particle whose largest dimension is limited by ferritin's inner diameter of 8 nm.
- the particles are produced first by removing the ferrihydrite core to yield apoferritin. The is done by dialysis against a buffered sodium acetate solution under a nitrogen flow. Reductive chelation using thioglycolic acid is used to remove the ferrihydrite core. This is followed by repeated dialysis against a sodium chloride solution to completely remove the reduced ferrihydrite core from solution.
- ferr- or ferromagnetic particles are incorporated in the following ways.
- the first is by reducing a metal salt solution in the presence of apoferritin. This is performed in an inert atmosphere to protect the metal particles from oxidation which would lessen their magnetic benefit.
- a combination of metal salts in solution can also be reduced to generate alloys or alloy precursors. Sintering or annealing in a magnetic field may be necessary to generate the useful magnetic alloys.
- Another method is to oxidise a combination of an iron(II) salt and another metal salt. This gives a metal ferrite particle which does not suffer negatively from oxidation.
- the metal salts which are beneficial include salts of aluminium, barium, bismuth, cerium, chromium, cobalt, copper, iron, manganese, molybdenum, neodymium, nickel, niobium, platinum, praseodymium, samarium, strontium, titanium, vanadium, ytterbium, and yttrium.
- a narrow size distribution of particles is necessary to avoid media noise. Such a distribution can be obtained through a variety of procedures including, but not limited to, density gradient centrifugation or magnetic field separation.
- ferritin seems to be an ideal system for generating nanoscale particles, it is not the only system available.
- flagellar L-P rings are tubular proteins with an inner diameter of 13 nm. By creating a 2-D array of these proteins, metal films could be deposited into the tubular centres to create perpendicular rods of magnetic material. Also metal reduction in the presence of a microemulsion can be used to generate nanoscale particles which are coated with surfactant. This invention is open to other nanoscale particle production methods.
- an ordered arrangement of the particles is desired.
- One way to accomplish this is by injecting an aqueous solution of particles into an MES/glucose subphase solution contained in a Teflon trough.
- the particles spread at the air-subphase interface, and a portion denature to form a monolayer film.
- the 2-D arrangement of encased particles occurs underneath this monolayer.
- the arrangement and monolayer are transferred to a substrate by placing the substrate directly onto the monolayer for 5 minutes. After withdrawing the substrate, the attached arrangement is coated with a thin layer of carbon for protection.
- Other methods such as solution evaporation onto a solid substrate can also give 2-D arrangements, and this invention should not be seen as limited in its arrangement methods.
- This example illustrates the preparation of apoferritin from horse spleen ferritin.
- Apoferritin was prepared from cadmium-free native horse spleen ferritin (CalBiochem, 100 mg/ml) by dialysis (molecular weight cut-off of 10-14 kDaltons) against sodium acetate solution (0.2 M) buffered at pH 5.5 under a nitrogen flow with reductive chelation using thioglycolic acid (0.3 M) to remove the ferrihydrite core. This is followed by repeated dialysis against sodium chloride solution (0.15 M) to completely remove the reduced ferrihydrite core from solution.
- This example illustrates the preparation of cobalt metal within apoferritin.
- the apoprotein is added to a deaerated TES/sodium chloride solution (0.1/0.4 M) buffered at pH 7.5 to give an approximate 1 mg/ml working solution of the protein.
- a deaerated cobalt(II) [for example, as the acetate salt] solution (1 mg/ml) was added incrementally such that the total number of atoms added was approximately 500 atoms/apoprotein molecule. This was allowed to stir at room temperature for one day in an inert atmosphere. This is followed by reduction of the cobalt(II) salt with sodium borohydride to cobalt(0) metal.
- the final product yielded a solution of cobalt particles, each surrounded by a ferritin shell.
- This example illustrates the preparation of a metal alloy such as yttrium cobalt (YCo 5 ) within apoferritin.
- the metal alloy follows the same procedure as Example 2 but using a 1:5 ratio of yttrium(III) [for example, as the acetate salt] to cobalt(II) [for example, as the acetate salt].
- the final product yielded a solution of yttrium cobalt particles, each surrounded by a ferritin shell.
- This example illustrates the preparation of a metal ferrite such as cobalt ferrite (CoO ⁇ Fe 2 O 3 ) within apoferritin.
- the apoprotein is added to a deaerated MES/sodium chloride solution (0.1/0.4 M) buffered at pH 6 to give an approximate 1 mg/ml working solution of the protein.
- a deaerated solution of cobalt(II) [for example, as the acetate salt] and iron(II) [for example, as the ammonium sulphate salt] in a ratio of 1:2 is added incrementally and allowed to air-oxidise.
- the final product yielded a solution of cobalt ferrite particles, each surrounded by a ferritin shell.
- This example illustrates the 2-D arrangement of ferritin-encased magnetic particles.
- An aqueous solution of particles [from Examples 2-4, and whose uniformity in size has been selected] is injected into an MES/glucose subphase solution (0.01 M/2%) contained in a Teflon trough.
- the particles spread at the air-subphase interface, and a portion denature to form a monolayer film.
- the 2-D arrangement of encased particles occurs underneath this monolayer. After 10 minutes at room temperature, the arrangement and monolayer are transferred to a substrate by placing the substrate directly onto the monolayer for 5 minutes. After withdrawing the substrate, the attached arrangement is coated with a thin layer of carbon for protection.
Abstract
A composition that includes a plurality of uniformly sized ferri- or ferromagnetizable particles, each particle having a largest dimension no greater than about 100 nm and being at least partially encased within an organic macromolecule, is disclosed herein.
Description
- This application is a continuation of U.S. Ser. No. 09/730,117, filed on Dec. 5, 2000, which is a continuation of U.S. Ser. No. 09/308,166, filed on Jun. 25, 1999, which is a national stage application of International Application No. PCT/GB97/03152, filed Nov. 17, 1997, which claims priority to Great Britain application No. 9623851.4, filed on Nov. 16, 1996.
- This invention relates to a magnetizable device which comprises a magnetic layer composed of domain-separated, nanoscale (e.g. 1-100 nm) ferromagnetic particles. The magnetizable device of the invention may be used as a magnetic storage device having improved data storage characteristics. In particular, the invention relates to magnetic storage media comprising single-domain, domain-separated, uniform, ferromagnetic nanoscale (e.g. 1-100 nm) particles which may be arranged into a regular 2-D packed array useful in the storage of information.
- Among the possible pathways to ultrahigh-density (>=1 Gbit/in2) magnetic media is the use of nanoscale (1-100 nm) particles. Beyond the standard requirements for magnetic media, a viable particulate media should have a small standard deviation in particle size as well as the particles being exchange decoupled. These requirements are necessary to avoid adverse media noise. Current methods of fabricating nanoscale particles, such as arc-discharge or multiple target ion-beam sputtering, have not fully addressed these two requirements. Moreover, if the uniform particles are arranged into an ordered array, each particle can represent a “bit” of information at a predictable location further increasing the media's efficiency. This invention details methods of producing particulate media that meet these requirements for ultrahigh-density recording. This invention is also an open system which allows for the production of a variety of magnetic materials, such that the media can be tuned for different applications.
- In particular this invention details the use of an iron storage protein, ferritin, whose internal cavity is used to produce the nanoscale particles. Ferritin is utilised in iron metabolism throughout living species and its structure is highly conserved among them. It consists of 24 subunits which are arranged to provide a hollow shell roughly 8 nm in diameter. The cavity normally stores 4500 iron(III) atoms in the form of paramagnetic ferrihydrite. However, this ferrihydrite can be removed (a ferritin devoid of ferrihydrite is termed “apoferritin”) and other materials may be incorporated. Examples include ceramics, superparamagnetic magnetite, acetaminophen, and even the sweetener aspartame. To address magnetic media concerns, the invention incorporates ferromagnetically ordered materials.
- According to a first aspect of the present invention, there is provided a magnetizable device which comprises a magnetic layer composed of domain-separated, ferromagnetic particles each of which has a largest dimension no greater than 100 nm.
- According to a second aspect of the invention, there is provided a magnetic recording medium which includes a magnetizable layer, wherein said magnetizable layer comprises a plurality of ferromagnetic particles each having a largest dimension no greater than 100 nm, and each of which particles represents a separate ferromagnetic domain. The magnetizable layer is preferably supported on a non-magnetic substrate.
- According to a third aspect of the present invention, there is provided a magnetic composition comprising a plurality of ferromagnetic particles each of which is bound to an organic macromolecule, and each of which has a largest dimension no greater than 100 nm. In this aspect of the invention, it is preferred that said organic macromolecule is ferritin from which the normal core ferrihydrite has been removed and replaced by a ferromagnetic particle.
- As used herein, the term “ferromagnetic” embraces materials which are either “ferromagnetic” and “ferrimagnetic”. Such usage is common in the electrical engineering art.
- The ferromagnetic particles used in the invention should be of a material and size such that they possess ferromagnetic properties at ambient temperatures (e.g. 15° C. to 30° C.),
- Preferably, the ferromagnetic particles each have a largest dimension no greater than 50 nm, more preferably less than 25 nm and most preferably smaller than 15 nm. The largest dimension of the ferromagnetic particles should not be so small that the particle will lose its ferromagnetic property and become superparamagnetic at the desired operating temperature of the recording medium. Typically, for operation at ambient temperature, this means that the magnetic particles will normally be no smaller than about 3 nm in their largest diameter.
- In the magnetizable device of the first aspect of this invention and the magnetic recording medium of the second aspect of this invention, the distance between adjacent ferromagnetic domains is preferably as small as possible to permit the maximum number of discrete domains in a given area, and provide the maximum storage capacity for the recording medium. The actual lower limit will vary for different materials and other conditions such as the temperature at which the recording medium is to be used. The key requirement, however, is that neighbouring domains should not be able to interfere magnetically with each other to the extent that the magnetic alignment of any domain can be altered by neighbouring domains. Typically, the lower limit on the spacing of the domains is about 2 nm. The distance between adjacent domains will be determined by the density of discrete domains required. Typically, however, to take advantage of the miniaturization possibilities provided by the invention, the distance between adjacent domains will be no greater than 10 nm.
- Generally the particles will be uniform in size, by which we mean that the particles do not vary in largest diameter by more than about 5%. One of the advantages of the use in the invention of an organic macromolecule which binds a magnetic particle by surrounding it is that this can be used to select particles of a uniform size.
- In the case where the particles are spheroidal, it will be the diameter of the particles which must be no greater than 100 nm.
- In preferred embodiments of all aspects of this invention, each ferromagnetic particle is encased, or partially encased, within an organic macromolecule. The term macromolecule means a molecule, or assembly of molecules, and may have a molecular weight of up 1500 kD, typically less than 500 kD. Ferritin has a molecular weight of 400 kD.
- The macromolecule should be capable of binding by encasing or otherwise organising the magnetic particle, and may therefore comprise a suitable cavity capable of containing the particle; a cavity will normally be fully enclosed within the macromolecule. Alternatively, the macromolecule may include a suitable opening which is not fully surrounded, but which nevertheless is capable of receiving and supporting the magnetic particle; for example, the opening may be that defined by an annulus in the macromolecule. For example, suitable macromolecules which may be used in the invention are proteins, for example the protein apoferritin (which is ferritin in which the cavity is empty), flagellar L-P rings, cyclodextrins, self-assembled cyclic peptides. As an alternative to encasing the magnetic particles within the macromolecule, they may be organised on the macromolecule, such as on a bacterial S-layer.
- Other materials which may be used in the invention to organise the ferromagnetic particles are inorganic-silica networks such as MCM type materials, dendrimers and micellar type systems.
- The presently preferred macromolecule for use in the invention is the apoferritin protein which has a cavity of the order of 8 nm in diameter. The ferri- or ferromagnetic particles to be accommodated within this protein should have a diameter no greater than 8 nm.
- The bound particles of this aspect of the present invention with a coating that inhibits aggregation and oxidation, also helping them to be domain-separated.
- In the magnetizable device of the first aspect of this invention and the magnetic recording medium of the second aspect of this invention, the particles are preferably arranged in a 2-D ordered array which would yield an ultrahigh-density magnetic media.
- The ferromagnetic material may be a metal, such as cobalt, iron, or nickel; a metal alloy, such as an alloy which contains aluminium, barium, bismuth, cerium, chromium, cobalt, copper, iron, manganese, molybdenum, neodymium, nickel, niobium, platinum, praseodymium, samarium, strontium, titanium, vanadium, ytterbium, yttrium or a mixture thereof; a metal ferrite such as a ferrite containing barium, cobalt, or strontium; or an organic ferromagnetic material.
- When generating nanoscale particles, one major concern is that the particles produced are not superparamagnetic. Superparamagnetic particles are those which have permanent magnetic dipole moments, but the moments' orientations with respect to the crystallographic axes fluctuate with time. This is not useful for a practical magnetic storage media. Superparamagnetism depends on the volume, temperature, and anisotropy of the particles. Via energy considerations, one can derive an equation relating these quantities. The volume at which a particle becomes superparamagnetic (Vp) is given by: VP=25 kT/K, where k is Boltzman's constant, T the temperature of the particle in degrees Kelvin, and K the anisotropy constant of the material. Using this formula, it is possible to determine the temperature at which a particle becomes superparamagnetic (the “blocking temperature”) for a given material at a fixed volume. In our specific case, the fixed volume is 8 nm in ferritin. If a cobalt metal particle with only crystalline anisotropy (that value being 45×105) is a sphere with a diameter of 8 nm, the blocking temperature is 353° K. This is within the range of temperatures experienced within a hard disk drive, and the cobalt particles may prove to be a useful storage medium. Obviously, there are other considerations such as the materials' coercivity, moment, saturation magnetisation, and relaxation time. By tuning the materials incorporated into the ferritin, though, these can be addressed.
- Ferritin is utilised in iron metabolism throughout living species and its structure is highly conserved among them. It consists of 24 subunits arranged in a 432 symmetry which provide a hollow shell roughly 8 nm in diameter. The cavity normally stores 4500 iron(III) atoms in the form of paramagnetic ferrihydrite.
- However, this ferrihydrite can be removed (a ferritin devoid of ferrihydrite is termed “apoferritin”) and other materials may be incorporated. The subunits in ferritin pack tightly, however there are channels into the cavity at the 3-fold and 4-fold axes. Lining the 3-fold channels are residues which bind metals such as cadmium, zinc, and calcium. By introducing such divalent ions one can potentially bind ferritin molecules together, or at least encourage their proximal arrangement.
- One method of preparing a 2-D packed array of ferromagnetically ordered particles of uniform size up to 8 nm includes the removal of the ferrihydrite core from the native ferritin in aqueous solution, the incorporation of ferromagnetically ordered cobalt metal particles by sodium borohydride reduction of the aqueous Co(II) solution into the ferritin cavities, the generation of a narrow size distribution through ultracentrifugation, the injection of particles into an MES/glucose subphase solution upon which the 2-D array assembles, and the transfer of the 2-D array to a substrate which is then carbon coated. In this method, the ferritin source may be a vertebrate, invertebrate, plant, fungi, yeast, bacteria, or one produced through recombinant techniques.
- In the method described, a metal alloy core may be produced by sodium borohydride reduction of a water soluble metal salt. Other oxidation methods include carbon, carbon monoxide, hydrogen, or hydrazine hydrate solution. Alternatively, a suitable-solution may be oxidised to yield a metal ferrite core. Oxidation may be chemical or electrochemical to yield the metal ferrite.
- In this method, other methods of selecting a narrow size distribution may be employed such as short or long column meniscus depletion methods or magnetic field separation.
- Further, in this method, divalent metal salts containing cadmium, calcium, or zinc may be added into the subphase solution to aid in particle ordering.
- Further, in this, other methods of arranging the particles into a 2-D array may be employed, such as solution evaporation onto a solid substrate.
- Further, in this method, the 2-D array may be coated with carbon-based films such as hydrogenated or nitrogen doped diamond-like carbon, or with silicon-based films such as silicon dioxide.
- In the present invention, ferritin may be used to enclose a ferromagnetic particle whose largest dimension is limited by ferritin's inner diameter of 8 nm. The particles are produced first by removing the ferrihydrite core to yield apoferritin. The is done by dialysis against a buffered sodium acetate solution under a nitrogen flow. Reductive chelation using thioglycolic acid is used to remove the ferrihydrite core. This is followed by repeated dialysis against a sodium chloride solution to completely remove the reduced ferrihydrite core from solution. Once the apoferritin is produced, ferr- or ferromagnetic particles are incorporated in the following ways. The first is by reducing a metal salt solution in the presence of apoferritin. This is performed in an inert atmosphere to protect the metal particles from oxidation which would lessen their magnetic benefit. A combination of metal salts in solution can also be reduced to generate alloys or alloy precursors. Sintering or annealing in a magnetic field may be necessary to generate the useful magnetic alloys. Another method is to oxidise a combination of an iron(II) salt and another metal salt. This gives a metal ferrite particle which does not suffer negatively from oxidation. The metal salts which are beneficial include salts of aluminium, barium, bismuth, cerium, chromium, cobalt, copper, iron, manganese, molybdenum, neodymium, nickel, niobium, platinum, praseodymium, samarium, strontium, titanium, vanadium, ytterbium, and yttrium.
- A narrow size distribution of particles is necessary to avoid media noise. Such a distribution can be obtained through a variety of procedures including, but not limited to, density gradient centrifugation or magnetic field separation.
- While the production procedure detailed uses native horse spleen ferritin, this invention should not be seen as limited to that source. Ferritin can be found in vertebrates, invertebrates, plants, fungi, yeasts, bacteria, or even produced through recombinant-techniques. By creating mutant apoferritins lacking the divalent binding site, others have found that the mutant proteins assemble into oblique assemblies as opposed to the regular hexagonal close-packed.
- While ferritin seems to be an ideal system for generating nanoscale particles, it is not the only system available. For example, flagellar L-P rings are tubular proteins with an inner diameter of 13 nm. By creating a 2-D array of these proteins, metal films could be deposited into the tubular centres to create perpendicular rods of magnetic material. Also metal reduction in the presence of a microemulsion can be used to generate nanoscale particles which are coated with surfactant. This invention is open to other nanoscale particle production methods.
- Finally an ordered arrangement of the particles is desired. One way to accomplish this is by injecting an aqueous solution of particles into an MES/glucose subphase solution contained in a Teflon trough. The particles spread at the air-subphase interface, and a portion denature to form a monolayer film. The 2-D arrangement of encased particles occurs underneath this monolayer. After 10 minutes at room temperature, the arrangement and monolayer are transferred to a substrate by placing the substrate directly onto the monolayer for 5 minutes. After withdrawing the substrate, the attached arrangement is coated with a thin layer of carbon for protection. Other methods such as solution evaporation onto a solid substrate can also give 2-D arrangements, and this invention should not be seen as limited in its arrangement methods.
- This example illustrates the preparation of apoferritin from horse spleen ferritin. Apoferritin was prepared from cadmium-free native horse spleen ferritin (CalBiochem, 100 mg/ml) by dialysis (molecular weight cut-off of 10-14 kDaltons) against sodium acetate solution (0.2 M) buffered at pH 5.5 under a nitrogen flow with reductive chelation using thioglycolic acid (0.3 M) to remove the ferrihydrite core. This is followed by repeated dialysis against sodium chloride solution (0.15 M) to completely remove the reduced ferrihydrite core from solution.
- This example illustrates the preparation of cobalt metal within apoferritin. The apoprotein is added to a deaerated TES/sodium chloride solution (0.1/0.4 M) buffered at pH 7.5 to give an approximate 1 mg/ml working solution of the protein. A deaerated cobalt(II) [for example, as the acetate salt] solution (1 mg/ml) was added incrementally such that the total number of atoms added was approximately 500 atoms/apoprotein molecule. This was allowed to stir at room temperature for one day in an inert atmosphere. This is followed by reduction of the cobalt(II) salt with sodium borohydride to cobalt(0) metal. The final product yielded a solution of cobalt particles, each surrounded by a ferritin shell.
- This example illustrates the preparation of a metal alloy such as yttrium cobalt (YCo5) within apoferritin. The metal alloy follows the same procedure as Example 2 but using a 1:5 ratio of yttrium(III) [for example, as the acetate salt] to cobalt(II) [for example, as the acetate salt]. The final product yielded a solution of yttrium cobalt particles, each surrounded by a ferritin shell.
- This example illustrates the preparation of a metal ferrite such as cobalt ferrite (CoO·Fe2O3) within apoferritin. The apoprotein is added to a deaerated MES/sodium chloride solution (0.1/0.4 M) buffered at pH 6 to give an approximate 1 mg/ml working solution of the protein. A deaerated solution of cobalt(II) [for example, as the acetate salt] and iron(II) [for example, as the ammonium sulphate salt] in a ratio of 1:2 is added incrementally and allowed to air-oxidise. The final product yielded a solution of cobalt ferrite particles, each surrounded by a ferritin shell.
- This example illustrates the 2-D arrangement of ferritin-encased magnetic particles. An aqueous solution of particles [from Examples 2-4, and whose uniformity in size has been selected] is injected into an MES/glucose subphase solution (0.01 M/2%) contained in a Teflon trough. The particles spread at the air-subphase interface, and a portion denature to form a monolayer film. The 2-D arrangement of encased particles occurs underneath this monolayer. After 10 minutes at room temperature, the arrangement and monolayer are transferred to a substrate by placing the substrate directly onto the monolayer for 5 minutes. After withdrawing the substrate, the attached arrangement is coated with a thin layer of carbon for protection.
Claims (8)
1. A magnetizable device which comprises a magnetic layer composed of domain-separated, ferromagnetic particles each of which has a largest dimension no greater than 100 nm.
2. Magnetic recording medium which includes a magnetizable layer thereon, wherein said magnetizable layer comprises a plurality of ferromagnetic particles each having a largest dimension no greater than 100 nm, and each of which particles represents a separate ferromagnetic domain.
3. Magnetic recording medium according to claim 2 , wherein the distance between adjacent ferromagnetic domains is at least 2 nm.
4. Magnetic recording medium according to claim 2 or 3, wherein the distance between adjacent ferromagnetic domains is no greater than 10 nm.
5. Magnetic recording medium according to claim 1 , 2, 3 or 4, wherein each ferromagnetic particle is encased within an organic macromolecule.
6. Magnetic recording medium according to claim 5 , wherein each ferromagnetic particle is encased within the cavity or opening of a protein macromolecule.
7. Magnetic recording medium according to claim 6 , wherein each ferri- or ferromagnetic particle is encased within an apoferritin protein.
8. A magnetic composition comprising a plurality of ferromagnetic particles each of which is bound to an organic macromolecule, and each of which ferromagnetic particles has a largest dimension no greater than 100 nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/782,356 US20040159821A1 (en) | 1996-11-16 | 2004-02-19 | Magnetizable device |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9623851.4 | 1996-11-16 | ||
GB9623851A GB2319253A (en) | 1996-11-16 | 1996-11-16 | Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles |
US30816699A | 1999-06-25 | 1999-06-25 | |
US09/730,117 US6713173B2 (en) | 1996-11-16 | 2000-12-05 | Magnetizable device |
US10/782,356 US20040159821A1 (en) | 1996-11-16 | 2004-02-19 | Magnetizable device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/730,117 Continuation US6713173B2 (en) | 1996-11-16 | 2000-12-05 | Magnetizable device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040159821A1 true US20040159821A1 (en) | 2004-08-19 |
Family
ID=28676517
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/730,117 Expired - Fee Related US6713173B2 (en) | 1996-11-16 | 2000-12-05 | Magnetizable device |
US10/782,356 Abandoned US20040159821A1 (en) | 1996-11-16 | 2004-02-19 | Magnetizable device |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/730,117 Expired - Fee Related US6713173B2 (en) | 1996-11-16 | 2000-12-05 | Magnetizable device |
Country Status (1)
Country | Link |
---|---|
US (2) | US6713173B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060068232A1 (en) * | 2004-09-24 | 2006-03-30 | Hitachi Maxell, Ltd. | Magnetic tape |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060003163A1 (en) * | 1996-11-16 | 2006-01-05 | Nanomagnetics Limited | Magnetic fluid |
EP1262489A1 (en) * | 2001-05-14 | 2002-12-04 | Matsushita Electric Industrial Co., Ltd. | Complex comprising recombinant ferritin and a precious metal and DNA encoding said ferritin |
US8865347B2 (en) * | 2001-09-28 | 2014-10-21 | Siluria Technologies, Inc. | Digital alloys and methods for forming the same |
JP3961887B2 (en) * | 2002-06-10 | 2007-08-22 | 富士通株式会社 | Method for manufacturing perpendicular magnetic recording medium |
US20050064508A1 (en) | 2003-09-22 | 2005-03-24 | Semzyme | Peptide mediated synthesis of metallic and magnetic materials |
JP2004110917A (en) * | 2002-09-18 | 2004-04-08 | Hitachi Ltd | Magnetic recording medium, and magnetic disc device using the same and method for manufacturing the same |
US8264137B2 (en) * | 2006-01-03 | 2012-09-11 | Samsung Electronics Co., Ltd. | Curing binder material for carbon nanotube electron emission cathodes |
WO2007123846A2 (en) * | 2006-04-17 | 2007-11-01 | Rensselaer Polytechnic Institute | Synthesis, functionalization and assembly of monodisperse high-coercivity silica-capped fept nanomagnets of tunable size, composition and thermal stability from microemulsions |
US7960721B2 (en) * | 2006-05-19 | 2011-06-14 | Siluria Technologies, Inc. | Light emitting devices made by bio-fabrication |
US7615385B2 (en) | 2006-09-20 | 2009-11-10 | Hypres, Inc | Double-masking technique for increasing fabrication yield in superconducting electronics |
JP4149503B2 (en) * | 2006-12-07 | 2008-09-10 | 松下電器産業株式会社 | A method for two-dimensionally arranging ferritin on a substrate |
GB0706217D0 (en) * | 2007-03-29 | 2007-05-09 | Univ Bristol | Functional protein crystals |
US8178158B2 (en) * | 2008-06-02 | 2012-05-15 | Hitachi Global Storage Technologies Netherlands B.V. | Method for making a current-perpendicular-to-the-plane giant magnetoresistance (CPP-GMR) sensor with a confined-current-path (CCP) |
Citations (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3951904A (en) * | 1973-03-07 | 1976-04-20 | Kureha Kagaku Kogyo Kabushiki Kaisha | Electromagnetic wave absorbing material containing carbon microspheres |
US3966510A (en) * | 1973-08-15 | 1976-06-29 | Fuji Photo Film Co., Ltd. | Ferromagnetic powder for magnetic recording medium and method for preparation thereof |
US3975569A (en) * | 1972-04-04 | 1976-08-17 | Sanyo-Kokusaku Pulp Co., Ltd. | Magnetic recording element |
US4009111A (en) * | 1973-08-18 | 1977-02-22 | Fuji Photo Film Co., Ltd. | Magnetic recording medium |
US4096040A (en) * | 1977-03-25 | 1978-06-20 | United States Steel Corporation | Tripper beam |
US4214893A (en) * | 1977-11-07 | 1980-07-29 | Nippon Columbia Kabushikikaisha | Method of making a magnetic powder |
US4244354A (en) * | 1979-01-10 | 1981-01-13 | Williams Douglas J | Solar panel |
US4269826A (en) * | 1976-12-11 | 1981-05-26 | Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung | Physiological preparation containing loaded cells in suspension and a magnetic agent for local concentration thereof in a living body |
US4333961A (en) * | 1981-04-30 | 1982-06-08 | International Business Machines Corporation | Preparation of thin, aligned magnetic coatings |
US4425261A (en) * | 1980-03-24 | 1984-01-10 | Ytkemiska Institutet | Liquid suspension of particles of a metal belonging to the platinum group and a method for the manufacture of such a suspension |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4452896A (en) * | 1980-10-30 | 1984-06-05 | Blakemore Richard P | Culture medium and conditions for growth of magnetic bacteria |
US4454234A (en) * | 1981-12-30 | 1984-06-12 | Czerlinski George H | Coated magnetizable microparticles, reversible suspensions thereof, and processes relating thereto |
US4480256A (en) * | 1981-08-18 | 1984-10-30 | The Boeing Company | Microwave absorber |
US4533582A (en) * | 1982-05-21 | 1985-08-06 | International Business Machines Corporation | Stabilized magnetic recording materials and process for tailoring and stabilizing of magnetic recording materials |
US4666773A (en) * | 1981-05-07 | 1987-05-19 | Fuji Photo Film Co., Ltd. | Magnetic recording medium |
US4672040A (en) * | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US4778671A (en) * | 1986-07-14 | 1988-10-18 | Corning Glass Works | Preparation of unagglomerated metal oxide particles with uniform particle size |
US4814098A (en) * | 1986-09-06 | 1989-03-21 | Bellex Corporation | Magnetic material-physiologically active substance conjugate |
US4849210A (en) * | 1985-05-08 | 1989-07-18 | Molecular Biosystems, Inc. | Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents |
US5043101A (en) * | 1983-02-08 | 1991-08-27 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US5062991A (en) * | 1990-06-04 | 1991-11-05 | Coulter Corporation | In situ use of gelatin in the preparation of uniform ferrite particles |
US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
US5147841A (en) * | 1990-11-23 | 1992-09-15 | The United States Of America As Represented By The United States Department Of Energy | Method for the preparation of metal colloids in inverse micelles and product preferred by the method |
US5217804A (en) * | 1990-11-06 | 1993-06-08 | Eastman Kodak Company | Magnetic particles |
US5248589A (en) * | 1991-02-21 | 1993-09-28 | Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Separation of cells and biological macromolecules by ferritin conjugates |
US5262176A (en) * | 1986-07-03 | 1993-11-16 | Advanced Magnetics, Inc. | Synthesis of polysaccharide covered superparamagnetic oxide colloids |
US5304382A (en) * | 1989-08-18 | 1994-04-19 | Monsanto Company | Ferritin analogs |
US5328681A (en) * | 1991-01-19 | 1994-07-12 | Meito Sangyo Kabushiki Kaisha | Composition comprising magnetic metal oxide ultrafine particles and derivatized polysaccharides |
US5338617A (en) * | 1992-11-30 | 1994-08-16 | Motorola, Inc. | Radio frequency absorbing shield and method |
US5427767A (en) * | 1991-05-28 | 1995-06-27 | Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin | Nanocrystalline magnetic iron oxide particles-method for preparation and use in medical diagnostics and therapy |
US5437892A (en) * | 1992-08-31 | 1995-08-01 | Research Development Corporation Of Japan | Method for manufacturing a fine-particles two-dimensional aggregate from a liquid dispersion of fine particles |
US5443813A (en) * | 1991-06-06 | 1995-08-22 | Associated Universities, Inc. | Loading and conjugating cavity biostructures |
US5487954A (en) * | 1991-12-04 | 1996-01-30 | National Science Council | Non-acicular modified high coercivity iron oxides for high density magnetic recording and the processes of making the same |
US5491219A (en) * | 1993-06-11 | 1996-02-13 | Protein Magnetics | Ferritin with ferrimagnetically ordered ferrite core and method technical field |
US5505996A (en) * | 1992-10-28 | 1996-04-09 | Research Development Corporation Of Japan | Method for forming a two-dimensional thin film of particles |
US5512332A (en) * | 1985-10-04 | 1996-04-30 | Immunivest Corporation | Process of making resuspendable coated magnetic particles |
US5543226A (en) * | 1991-12-18 | 1996-08-06 | Basf Magnetics Gmbh | Magnetic recording media |
US5547748A (en) * | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
US5552229A (en) * | 1993-09-30 | 1996-09-03 | Basf Magnetics Gmbh | Magnetic recording medium containing magnetic material dispersed in a polyurethaneurea-polyurethane binder |
US5552072A (en) * | 1993-02-19 | 1996-09-03 | Daikin Industries Ltd. | Coated acicular fine particulate materials, processes for preparing same and use thereof |
US5574961A (en) * | 1985-01-16 | 1996-11-12 | The United States Of America As Represented By The Secretary Of The Navy | Phase-separated material (U) |
US5670078A (en) * | 1992-07-09 | 1997-09-23 | Xerox Corporation | Magnetic and nonmagnetic particles and fluid, methods of making and methods of using the same |
US5697902A (en) * | 1985-07-05 | 1997-12-16 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
US5766764A (en) * | 1996-06-04 | 1998-06-16 | The Boeing Company | Nanoscale amorphous magnetic metals |
US5843569A (en) * | 1996-09-13 | 1998-12-01 | Fujitsu Limited | Magnetic recording medium and device |
US5916539A (en) * | 1993-03-02 | 1999-06-29 | Silica Gel Ges. M.B.H. | Superparamagnetic particles, process for producing the same and their use |
US5965267A (en) * | 1995-02-17 | 1999-10-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for producing encapsulated nanoparticles and carbon nanotubes using catalytic disproportionation of carbon monoxide and the nanoencapsulates and nanotubes formed thereby |
US6054495A (en) * | 1996-02-20 | 2000-04-25 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of unagglomerated metal nano-particles at membrane interfaces |
US6103868A (en) * | 1996-12-27 | 2000-08-15 | The Regents Of The University Of California | Organically-functionalized monodisperse nanocrystals of metals |
US6162532A (en) * | 1998-07-31 | 2000-12-19 | International Business Machines Corporation | Magnetic storage medium formed of nanoparticles |
US6180389B1 (en) * | 1997-01-03 | 2001-01-30 | The Research And Development Institute, Inc. | Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules |
US6254662B1 (en) * | 1999-07-26 | 2001-07-03 | International Business Machines Corporation | Chemical synthesis of monodisperse and magnetic alloy nanocrystal containing thin films |
US20010055669A1 (en) * | 1994-10-18 | 2001-12-27 | Schultz Peter G. | Polymer arrays from the combinatorial synthesis of novel materials |
US6361161B1 (en) * | 2000-03-01 | 2002-03-26 | Eastman Kodak Company | Nanoparticles for printing images |
US6451220B1 (en) * | 1997-01-21 | 2002-09-17 | Xerox Corporation | High density magnetic recording compositions and processes thereof |
US20030017336A1 (en) * | 2001-07-16 | 2003-01-23 | Bar-Ilan Univeristy | Nanoscale metal particles and method of preparing same |
US20030048341A1 (en) * | 2000-09-25 | 2003-03-13 | Mutz Mitchell W. | High-throughput biomolecular crystallization and biomolecular crystal screening |
US20030059604A1 (en) * | 2001-09-05 | 2003-03-27 | Fuji Photo Film Co., Ltd. | Material coated with dispersion of ferromagnetic nanoparticles, and magnetic recording medium using the material |
US20030215634A1 (en) * | 2002-03-08 | 2003-11-20 | Fuji Photo Film Co., Ltd. | Nanoparticle coated material and production method of same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409041A (en) | 1980-09-26 | 1983-10-11 | Allied Corporation | Amorphous alloys for electromagnetic devices |
US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US4965007A (en) | 1988-05-10 | 1990-10-23 | Eastman Kodak Company | Encapsulated superparamagnetic particles |
GB9120508D0 (en) | 1991-09-26 | 1991-11-06 | Nycomed As | Diagnostic agents |
US6051614A (en) | 1991-12-28 | 2000-04-18 | Hidefumi Hirai | Method for preparing a non-aqueous dispersion of particles of a metal and/or a metal compound |
US5358659A (en) | 1992-07-09 | 1994-10-25 | Xerox Corporation | Magnetic materials with single-domain and multidomain crystallites and a method of preparation |
IT1270200B (en) | 1994-06-09 | 1997-04-29 | Ausimont Spa | PREPARATION OF ULTRA FINE PARTICLES FROM MICROEMULSIONS OF WATER IN OIL |
JP3812977B2 (en) | 1996-09-30 | 2006-08-23 | Necトーキン株式会社 | Electromagnetic interference suppressor |
NL1008528C2 (en) | 1998-03-09 | 1999-09-10 | Univ Utrecht | Ferromagnetic particles. |
US6262129B1 (en) | 1998-07-31 | 2001-07-17 | International Business Machines Corporation | Method for producing nanoparticles of transition metals |
DE60017017T2 (en) | 1999-01-27 | 2006-04-13 | Bayer Corp. | IMMUNTEST USING PARTICLES WITH CASEIN Hulls |
AU5146300A (en) | 1999-05-21 | 2000-12-12 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Magnetic resonance tracking of magnetically labeled cells |
AU4116401A (en) | 2000-03-16 | 2001-09-24 | Matsushita Electric Industrial Co., Ltd. | Nucleotide detector, process for producing the same and process for forming fineparticle membrane |
AU2001253041A1 (en) | 2000-03-31 | 2001-10-15 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health | Dendrimer composition for magnetic resonance analysis |
-
2000
- 2000-12-05 US US09/730,117 patent/US6713173B2/en not_active Expired - Fee Related
-
2004
- 2004-02-19 US US10/782,356 patent/US20040159821A1/en not_active Abandoned
Patent Citations (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3975569A (en) * | 1972-04-04 | 1976-08-17 | Sanyo-Kokusaku Pulp Co., Ltd. | Magnetic recording element |
US3951904A (en) * | 1973-03-07 | 1976-04-20 | Kureha Kagaku Kogyo Kabushiki Kaisha | Electromagnetic wave absorbing material containing carbon microspheres |
US3966510A (en) * | 1973-08-15 | 1976-06-29 | Fuji Photo Film Co., Ltd. | Ferromagnetic powder for magnetic recording medium and method for preparation thereof |
US4009111A (en) * | 1973-08-18 | 1977-02-22 | Fuji Photo Film Co., Ltd. | Magnetic recording medium |
US4269826A (en) * | 1976-12-11 | 1981-05-26 | Kernforschungsanlage Julich Gesellschaft Mit Beschrankter Haftung | Physiological preparation containing loaded cells in suspension and a magnetic agent for local concentration thereof in a living body |
US4096040A (en) * | 1977-03-25 | 1978-06-20 | United States Steel Corporation | Tripper beam |
US4214893A (en) * | 1977-11-07 | 1980-07-29 | Nippon Columbia Kabushikikaisha | Method of making a magnetic powder |
US4244354A (en) * | 1979-01-10 | 1981-01-13 | Williams Douglas J | Solar panel |
US4425261A (en) * | 1980-03-24 | 1984-01-10 | Ytkemiska Institutet | Liquid suspension of particles of a metal belonging to the platinum group and a method for the manufacture of such a suspension |
US4452896A (en) * | 1980-10-30 | 1984-06-05 | Blakemore Richard P | Culture medium and conditions for growth of magnetic bacteria |
US4333961A (en) * | 1981-04-30 | 1982-06-08 | International Business Machines Corporation | Preparation of thin, aligned magnetic coatings |
US4666773A (en) * | 1981-05-07 | 1987-05-19 | Fuji Photo Film Co., Ltd. | Magnetic recording medium |
US4480256A (en) * | 1981-08-18 | 1984-10-30 | The Boeing Company | Microwave absorber |
US4454234A (en) * | 1981-12-30 | 1984-06-12 | Czerlinski George H | Coated magnetizable microparticles, reversible suspensions thereof, and processes relating thereto |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4533582A (en) * | 1982-05-21 | 1985-08-06 | International Business Machines Corporation | Stabilized magnetic recording materials and process for tailoring and stabilizing of magnetic recording materials |
US5043101A (en) * | 1983-02-08 | 1991-08-27 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US4672040A (en) * | 1983-05-12 | 1987-06-09 | Advanced Magnetics, Inc. | Magnetic particles for use in separations |
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US5574961A (en) * | 1985-01-16 | 1996-11-12 | The United States Of America As Represented By The Secretary Of The Navy | Phase-separated material (U) |
US4849210A (en) * | 1985-05-08 | 1989-07-18 | Molecular Biosystems, Inc. | Magnetic resonance imaging of liver and spleen with superparamagnetic contrast agents |
US5697902A (en) * | 1985-07-05 | 1997-12-16 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
US5512332A (en) * | 1985-10-04 | 1996-04-30 | Immunivest Corporation | Process of making resuspendable coated magnetic particles |
US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
US5262176A (en) * | 1986-07-03 | 1993-11-16 | Advanced Magnetics, Inc. | Synthesis of polysaccharide covered superparamagnetic oxide colloids |
US4778671A (en) * | 1986-07-14 | 1988-10-18 | Corning Glass Works | Preparation of unagglomerated metal oxide particles with uniform particle size |
US4814098A (en) * | 1986-09-06 | 1989-03-21 | Bellex Corporation | Magnetic material-physiologically active substance conjugate |
US5358722A (en) * | 1989-08-18 | 1994-10-25 | Monsanto Company | Ferritin analogs |
US5304382A (en) * | 1989-08-18 | 1994-04-19 | Monsanto Company | Ferritin analogs |
US5062991A (en) * | 1990-06-04 | 1991-11-05 | Coulter Corporation | In situ use of gelatin in the preparation of uniform ferrite particles |
US5217804A (en) * | 1990-11-06 | 1993-06-08 | Eastman Kodak Company | Magnetic particles |
US5147841A (en) * | 1990-11-23 | 1992-09-15 | The United States Of America As Represented By The United States Department Of Energy | Method for the preparation of metal colloids in inverse micelles and product preferred by the method |
US5328681A (en) * | 1991-01-19 | 1994-07-12 | Meito Sangyo Kabushiki Kaisha | Composition comprising magnetic metal oxide ultrafine particles and derivatized polysaccharides |
US5248589A (en) * | 1991-02-21 | 1993-09-28 | Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Separation of cells and biological macromolecules by ferritin conjugates |
US5427767A (en) * | 1991-05-28 | 1995-06-27 | Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin | Nanocrystalline magnetic iron oxide particles-method for preparation and use in medical diagnostics and therapy |
US5443813A (en) * | 1991-06-06 | 1995-08-22 | Associated Universities, Inc. | Loading and conjugating cavity biostructures |
US5690903A (en) * | 1991-06-06 | 1997-11-25 | Hainfeld; James F. | Loading and conjugating cavity biostructures |
US5487954A (en) * | 1991-12-04 | 1996-01-30 | National Science Council | Non-acicular modified high coercivity iron oxides for high density magnetic recording and the processes of making the same |
US5543226A (en) * | 1991-12-18 | 1996-08-06 | Basf Magnetics Gmbh | Magnetic recording media |
US5670078A (en) * | 1992-07-09 | 1997-09-23 | Xerox Corporation | Magnetic and nonmagnetic particles and fluid, methods of making and methods of using the same |
US5437892A (en) * | 1992-08-31 | 1995-08-01 | Research Development Corporation Of Japan | Method for manufacturing a fine-particles two-dimensional aggregate from a liquid dispersion of fine particles |
US5505996A (en) * | 1992-10-28 | 1996-04-09 | Research Development Corporation Of Japan | Method for forming a two-dimensional thin film of particles |
US5338617A (en) * | 1992-11-30 | 1994-08-16 | Motorola, Inc. | Radio frequency absorbing shield and method |
US5552072A (en) * | 1993-02-19 | 1996-09-03 | Daikin Industries Ltd. | Coated acicular fine particulate materials, processes for preparing same and use thereof |
US5916539A (en) * | 1993-03-02 | 1999-06-29 | Silica Gel Ges. M.B.H. | Superparamagnetic particles, process for producing the same and their use |
US5491219A (en) * | 1993-06-11 | 1996-02-13 | Protein Magnetics | Ferritin with ferrimagnetically ordered ferrite core and method technical field |
US5552229A (en) * | 1993-09-30 | 1996-09-03 | Basf Magnetics Gmbh | Magnetic recording medium containing magnetic material dispersed in a polyurethaneurea-polyurethane binder |
US5547748A (en) * | 1994-01-14 | 1996-08-20 | Sri International | Carbon nanoencapsulates |
US20010055669A1 (en) * | 1994-10-18 | 2001-12-27 | Schultz Peter G. | Polymer arrays from the combinatorial synthesis of novel materials |
US5965267A (en) * | 1995-02-17 | 1999-10-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for producing encapsulated nanoparticles and carbon nanotubes using catalytic disproportionation of carbon monoxide and the nanoencapsulates and nanotubes formed thereby |
US6054495A (en) * | 1996-02-20 | 2000-04-25 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of unagglomerated metal nano-particles at membrane interfaces |
US5766764A (en) * | 1996-06-04 | 1998-06-16 | The Boeing Company | Nanoscale amorphous magnetic metals |
US5843569A (en) * | 1996-09-13 | 1998-12-01 | Fujitsu Limited | Magnetic recording medium and device |
US6103868A (en) * | 1996-12-27 | 2000-08-15 | The Regents Of The University Of California | Organically-functionalized monodisperse nanocrystals of metals |
US6180389B1 (en) * | 1997-01-03 | 2001-01-30 | The Research And Development Institute, Inc. | Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules |
US6451220B1 (en) * | 1997-01-21 | 2002-09-17 | Xerox Corporation | High density magnetic recording compositions and processes thereof |
US6162532A (en) * | 1998-07-31 | 2000-12-19 | International Business Machines Corporation | Magnetic storage medium formed of nanoparticles |
US6254662B1 (en) * | 1999-07-26 | 2001-07-03 | International Business Machines Corporation | Chemical synthesis of monodisperse and magnetic alloy nanocrystal containing thin films |
US20010009119A1 (en) * | 1999-07-26 | 2001-07-26 | International Business Machines Corporation | Chemical synthesis of monodisperse and magnetic alloy nanocrystal containing thin films |
US6361161B1 (en) * | 2000-03-01 | 2002-03-26 | Eastman Kodak Company | Nanoparticles for printing images |
US20030048341A1 (en) * | 2000-09-25 | 2003-03-13 | Mutz Mitchell W. | High-throughput biomolecular crystallization and biomolecular crystal screening |
US20030017336A1 (en) * | 2001-07-16 | 2003-01-23 | Bar-Ilan Univeristy | Nanoscale metal particles and method of preparing same |
US20030059604A1 (en) * | 2001-09-05 | 2003-03-27 | Fuji Photo Film Co., Ltd. | Material coated with dispersion of ferromagnetic nanoparticles, and magnetic recording medium using the material |
US20030215634A1 (en) * | 2002-03-08 | 2003-11-20 | Fuji Photo Film Co., Ltd. | Nanoparticle coated material and production method of same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060068232A1 (en) * | 2004-09-24 | 2006-03-30 | Hitachi Maxell, Ltd. | Magnetic tape |
Also Published As
Publication number | Publication date |
---|---|
US20030189791A1 (en) | 2003-10-09 |
US6713173B2 (en) | 2004-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6896957B1 (en) | Magnetizable device | |
US6713173B2 (en) | Magnetizable device | |
Warne et al. | Self assembled nanoparticulate Co: Pt for data storage applications | |
Weller et al. | Extremely high-density longitudinal magnetic recording media | |
JPS6035813B2 (en) | Method for manufacturing magnetic thin film structure | |
JP4531331B2 (en) | Magnetic thin film, manufacturing method thereof, evaluation method thereof, magnetic head using the same, magnetic recording apparatus and magnetic device | |
US6815063B1 (en) | Magnetic fluid | |
Carey et al. | The magnetic and magneto‐optical properties of Co, Cr, Mn, and Ni substituted barium ferrite films | |
JPH0268906A (en) | Highly saturated flux density soft magnetic film and magnetic head | |
CA1189200A (en) | Post treatment of perpendicular magnetic recording media | |
EP0247681B1 (en) | Magnetic material, magnetic recording medium, and method of manufacturing a magnetic material | |
JP3961887B2 (en) | Method for manufacturing perpendicular magnetic recording medium | |
MXPA99004542A (en) | Magnetizable device | |
WO2000015545A1 (en) | Method for controlling the shape of synthesis particles and for producing materials and devices containing oriented anisotropic particles and nanostructures | |
JP2775877B2 (en) | Perpendicular magnetic recording media | |
Mayes et al. | Mineralization in nanostructured biocompartments: biomimetic ferritins for high-density data storage | |
JP2842683B2 (en) | Soft magnetic thin film material | |
JP4101980B2 (en) | Non-magnetic single crystal ferrite, magnetic head substrate and magnetic head | |
Mayes et al. | Nanobiotechnology. Edited by Christof Niemeyer, Chad Mirkin Copyright© 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN 3-527-30658-7 | |
Rittner | Nanomagnetic Materials and Devices: Technology and Markets | |
JPS6281008A (en) | Amorphous high saturable magnetic flux density material | |
JPS6398823A (en) | Magnetic recording medium and its production | |
WO1998032902A1 (en) | Method of manufacturing crystalline particles on a support or a substrate | |
JPH09129444A (en) | Soft magnetic thin film for high frequency | |
JPS63316312A (en) | Magnetic recording medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NANOMAGNETICS LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAYES, ERIC;TYLER, MALVIN;REEL/FRAME:016156/0839 Effective date: 19981127 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |